Squarepoint Ops LLC Ultragenyx Pharmaceutical Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$37.42 - $51.61 $1.44 Million - $1.99 Million	-38,540 Reduced 67.47%	18,585 $763,000
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $1.78 Million - $2.22 Million	41,284 Added 260.61%	57,125 $2.67 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $135,899 - $210,680	4,283 Added 37.06%	15,841 $757,000
Q2 2023 Aug 14, 2023	BUY	$37.35 - $52.15 $431,691 - $602,749	11,558 New	11,558 $533,000
Q4 2022 Feb 14, 2023	SELL	$33.72 - $46.33 $4.06 Million - $5.57 Million	-120,314 Reduced 95.55%	5,597 $259,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $2.95 Million - $4.88 Million	73,806 Added 141.65%	125,911 $5.21 Million
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $985,936 - $1.84 Million	21,527 Added 70.4%	52,105 $3.11 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $1.9 Million - $2.58 Million	30,578 New	30,578 $2.22 Million
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $5.22 Million - $6.86 Million	-67,005 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $5.84 Million - $7.33 Million	63,355 Added 1735.75%	67,005 $6.39 Million
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $390,185 - $612,214	3,650 New	3,650 $416,000
Q4 2020 Feb 16, 2021	SELL	$84.4 - $177.39 $2.83 Million - $5.95 Million	-33,537 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $1.95 Million - $2.4 Million	26,663 Added 387.88%	33,537 $2.76 Million
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $353,842 - $590,013	-7,543 Reduced 52.32%	6,874 $538,000
Q1 2020 May 15, 2020	SELL	$33.8 - $62.9 $1.53 Million - $2.85 Million	-45,299 Reduced 75.86%	14,417 $641,000
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $1.77 Million - $2.25 Million	49,020 Added 458.3%	59,716 $2.55 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $93,967 - $139,536	2,211 Added 26.06%	10,696 $458,000
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $466,081 - $630,944	8,485 New	8,485 $539,000
Q1 2019 May 15, 2019	SELL	$39.87 - $69.36 $1.29 Million - $2.24 Million	-32,253 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $1.25 Million - $2.49 Million	32,253 New	32,253 $1.4 Million
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $287,364 - $378,312	-6,600 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $328,614 - $437,711	6,600	6,600 $352,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$446 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$251 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$230 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$187 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$138 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account